TRODELVY

Indicated For

metastatic triple-negative breast cancer, urothelial cancer

About This Medication

# Gilead Patient Assistance Program Patient Guide: How to Get TRODELVY (sacituzumab govitecan-hziy) at Low or No Cost TRODELVY (sacituzumab govitecan-hziy) is a prescription medication used to treat certain types of metastatic breast cancer in adults who have received prior treatment. The **Gilead Patient Assistance Program** (also called PAP or Medication Assistance Program/MAP) helps eligible uninsured or underinsured US residents access TRODELVY at no cost if they meet income and other criteria. ## About TRODELVY **TRODELVY** is an antibody-drug conjugate approved by the FDA for treating unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) in adults who have received at least two prior therapies. It works by targeting cancer cells with a topoisomerase inhibitor payload, helping to slow cancer growth. Always consult your doctor for personalized medical advice, as this guide focuses on access, not treatment details. ## Who Qualifies for the Program? The Gilead Patient Assistance Program is designed for **legal US residents** (including Puerto Rico and US territories) who are **uninsured or underinsured** and meet **income requirements** and other eligibility criteria. You must have a valid prescription from a licensed healthcare provider. Government insurance like Medicare or Medicaid typically does not qualify for this free medication program—separate options exist for commercially insured patients via the Co-pay Savings Program. ### Income Eligibility Breakdown Specific Federal Poverty Level (FPL) percentages or exact income thresholds (e.g., for individuals, couples, or families) are not publicly detailed online and vary based on household size and current guidelines. Program specialists determine eligibility during enrollment, often requiring proof of all income sources. Contact the program at **(844) 876-3358** for your personalized assessment. Here's a general overview based on standard patient assistance structures (confirm with program for TRODELVY specifics): | Household Size | Estimated Max Annual Income (e.g., ~400-500% FPL)* | |----------------|---------------------------------------------------| | 1 (Individual) | $60,000 - $75,000 | | 2 (Couple) | $80,000 - $100,000 | | 3 | $100,000 - $125,000 | | 4 | $120,000 - $150,000 | | 5+ | Add ~$20,000 - $25,000 per additional member | *These are illustrative estimates; actual thresholds require verification. Provide recent pay stubs, tax returns, W-2s, or other income docs. ## Insurance Requirements - **Uninsured**: Fully eligible if other criteria met. - **Underinsured**: May qualify if high out-of-pocket costs; commercial/private insurance users should explore the Co-pay Savings Program first. - **Not eligible**: Medicare, Medicaid, VA, Tricare, or other government programs. Proof of insurance status (front/back of card) is required. ## Step-by-Step Application Process 1. **Get a Prescription**: Ask your doctor to prescribe TRODELVY and discuss if they can assist with enrollment via the iAssist portal for healthcare providers. 2. **Contact the Program**: Call **(844) 876-3358** (or 1-800-226-2056 for Advancing Access support, Mon-Fri 9 AM-8 PM ET) to speak with a specialist. They guide you and may offer immediate eligibility checks. 3. **Complete Enrollment Form**: Download from GileadAdvancingAccess.com or request by phone. Both you and your prescriber must sign. Multiple methods available: - **Phone**: (844) 876-3358 - **Fax**: Use form-specific fax (e.g., 1-800-216-6857 or similar). - **Online**: Via provider iAssist portal or patient portal. - **Mail**: As instructed. 4. **Gather Required Documents**: - Completed enrollment form. - Proof of insurance (or lack thereof). - Proof of income (pay stubs, tax returns, etc.). - Proof of residency/ID. - Prescriber information and prescription. 5. **Submit**: Fax, mail, or submit electronically. Expect a call from a specialist for next steps. 6. **Await Approval**: Reviewed in about **2 business days**. You'll be notified by phone. ## Timeline and Delivery - **Processing**: 2 business days for review; immediate decisions possible online. - **Approval Duration**: Varies; reauthorization required periodically. - **Delivery**: Medication shipped free to your home or doctor's office. - **Refills**: Contact program before running out; doctor may need to re-certify. ## If Denied or Alternatives If denied (e.g., income too high, insurance issues), ask for reasons and reapply with updated info. Alternatives: - **Co-pay Program**: For commercial insurance (enroll via same phone). - **State Assistance**: Check ADAP or local programs (if applicable). - **Manufacturer Appeal**: Request review. - **Other PAPs**: NeedyMeds.org or RxAssist.org for TRODELVY alternatives. - No biosimilar alternatives currently available. ## Reauthorization Yes, required. Your doctor submits updates; program notifies when needed. ## Disclaimer This guide is for informational purposes only and based on publicly available program details as of general knowledge. Eligibility, terms, and benefits can change—**always verify directly with Gilead at (844) 876-3358**. Not medical advice; consult your healthcare provider. Gilead reserves rights to modify or end the program. Word count: ~950.

Program information last verified: March 30, 2026